DGX vs RVTY — Key Metrics

Metric DGX (QUEST DIAGNOSTICS INC) RVTY (REVVITY INC)
Price259.69152.43
Market Cap28.57 Billion17.02 Billion
P/E (TTM)25.5167.75
P/B (Quarterly)3.4872.443
P/S (TTM)2.415.78
Net Profit Margin (TTM)9.58.6
Gross Margin (TTM)33.155.9
ROE (TTM)15.23.5
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

QUEST DIAGNOSTICS INC
vs
 
REVVITY INC
 
QUEST DIAGNOSTICS INC
vs
 
REVVITY INC
Performance Comparison
AI Model Recommendation
DGX · QUEST DIAGNOSTICS INC

Underperform

-8
UnderperformOutperform
RVTY · REVVITY INC

Underperform

-46
UnderperformOutperform
Recommendation Summary

Both stocks are projected to underperform the market over the next year. If you have to make a choice, Upfront Recommendation: DGX.

Financial Metrics
Prices delayed ~15 min
DGX Metrics RVTY
$259.69 Price $152.43
— Market Capitalization —
25.51 Price to Earnings Ratio 67.75
2.41 Price to Sales 5.78
20.78 Price to FCF Ratio 28.24
7.29 Price to Gross Profit 10.35
9.17 Price to Current Assets 9.14

DGX vs RVTY at a glance

Quest Diagnostics INC (DGX) and Revvity INC (RVTY) are both Diagnostics & Research companies in the Healthcare sector. DGX is the larger, at $28.6 billion in market value against $17.0 billion for RVTY, about 1.7 times the size.

On trailing-twelve-month figures, DGX trades at 25.5 times trailing earnings and RVTY at 67.8; net profit margins are 9.5% and 8.6%.

The Upfront Investment model currently rates both Underperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.